Literature DB >> 24306456

A mild removal of Fmoc group using sodium azide.

Chun-Chi Chen1, Basker Rajagopal, Xuan Yu Liu, Kuan Lin Chen, Yu-Chang Tyan, Fui Lin, Po-Chiao Lin.   

Abstract

A mild method for effectively removing the fluorenylmethoxycarbonyl (Fmoc) group using sodium azide was developed. Without base, sodium azide completely deprotected N (α)-Fmoc-amino acids in hours. The solvent-dependent conditions were carefully studied and then optimized by screening different sodium azide amounts and reaction temperatures. A variety of Fmoc-protected amino acids containing residues masked with different protecting groups were efficiently and selectively deprotected by the optimized reaction. Finally, a biologically significant hexapeptide, angiotensin IV, was successfully synthesized by solid phase peptide synthesis using the developed sodium azide method for all Fmoc removals. The base-free condition provides a complement method for Fmoc deprotection in peptide chemistry and modern organic synthesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24306456     DOI: 10.1007/s00726-013-1625-7

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  3 in total

1.  GAP Peptide Synthesis via Design of New GAP Protecting Group: An Fmoc/tBu Synthesis of Thymopentin Free from Polymers, Chromatography and Recrystallization.

Authors:  Cole W Seifert; Armando Paniagua; Gabrielle A White; Lucy Cai; Guigen Li
Journal:  European J Org Chem       Date:  2016-03-08

2.  A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides.

Authors:  Ghullam Reza Barbari; Farid Abedin Dorkoosh; Mohsen Amini; Mohammad Sharifzadeh; Fateme Atyabi; Saeed Balalaie; Niyousha Rafiee Tehrani; Morteza Rafiee Tehrani
Journal:  Int J Nanomedicine       Date:  2017-05-02

3.  Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.

Authors:  Ghullam Reza Barbari; Farid Dorkoosh; Mohsen Amini; Nika Bahari Javan; Mohammad Sharifzadeh; Fateme Atyabi; Saeed Balalaie; Niyousha Rafiee Tehrani; Morteza Rafiee Tehrani
Journal:  Int J Nanomedicine       Date:  2018-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.